Retraction: Correlation of CCNA1 promoter methylation with malignant tumors: A meta-analysis introduction (BioMed Research International (2015) 2015 (134027) DOI: 10.1155/2015/134027);Correlation of CCNA1 promoter methylation with malignant tumors: A meta-analysis introduction

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Yang, Bin ^a   Miao, Shuai ^a   Zhang, Le Ning ^a   Sun, Hong Bin ^a   Xu, Zhe Nan ^a   Han, Chun Shan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A1; CCNA1 PROTEIN, HUMAN;

CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CASE CONTROL STUDY; CCNA1 GENE; DNA METHYLATION; ETHNICITY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS; PROMOTER REGION; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; GENETIC PREDISPOSITION; GENETICS; NEOPLASM; PATHOLOGY; PUBLISHING;

CYCLIN A1; DNA METHYLATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS;

EID: 84947650497     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2021/2608067     Document Type: Erratum

References (36)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics, " CA: Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. A. E. Simon, J. Waller, K. Robb, and J. Wardle, "Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom, " Cancer Epidemiology, Biomarkers and Prevention, vol. 19, no. 9, pp. 2272-2277, 2010.
3. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013, " CA:ACancer Journal for Clinicians, vol. 63, no. 1, pp. 11-30, 2013.
4. A. McTiernan, M. Irwin, and V. VonGruenigen, "Weight, physical activity, diet, and prognosis in breast and gynecologic cancers, " Journal of Clinical Oncology, vol. 28, no. 26, pp. 4074-4080, 2010.
5. M. Brait, S. Begum, A. L. Carvalho et al., "Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer, " Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 10, pp. 2786-2794, 2008.
6. S. Iodice, S. Gandini, P. Maisonneuve, and A. B. Lowenfels, "Tobacco and the risk of pancreatic cancer: a review and metaanalysis, " Langenbecks Archives of Surgery, vol. 393, no. 4, pp. 535-545, 2008.
7. S. M. Zhang, I.-M. Lee, J. E. Manson, N. R. Cook, W. C. Willett, and J. E. Buring, "Alcohol consumption and breast cancer risk in the womens health study, " American Journal of Epidemiology, vol. 165, no. 6, pp. 667-676, 2007.
8. S. Sadetzki, A. Chetrit, A. Lubina, M. Stovall, and I. Novikov, "Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis, " The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 12, pp. 4798-4804, 2006.
9. N. Yang, E. R. Nijhuis, H. H. Volders et al., "Gene promoter methylation patterns throughout the process of cervical carcinogenesis, " Cellular Oncology, vol. 32, no. 1-2, pp. 131-143, 2010.
10. D. Weiss, T. Basel, F. Sachse, A. Braeuninger, and C. Rudack, "Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation, " Molecular Carcinogenesis, vol. 50, no. 9, pp. 680-688, 2011.
11. S. Lapenna and A. Giordano, "Cell cycle kinases as therapeutic targets for cancer, " Nature Reviews Drug Discovery, vol. 8, no. 7, pp. 547-566, 2009.
12. Y. Tokumaru, K. Yamashita, M. Osada et al., "Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing, " Cancer Research, vol. 64, no. 17, pp. 5982-5987, 2004.
13. A. S. Syed Khaja, N. Dizeyi, P. K. Kopparapu, L. Anagnostaki, P. Härkönen, and J. L. Persson, "Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer, " PLoS ONE, vol. 8, no. 8, Article ID e72210, 2013.
14. V. Sriuranpong, A. Mutirangura, J. W. Gillespie et al., "Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays, " Clinical Cancer Research, vol. 10, no. 15, pp. 4944-4958, 2004.
15. C. Muller-Tidow, P. Ji, S. Diederichs et al., "Thecyclin A1-CDK2 complex regulates DNA double-strand break repair, " Molecular and Cellular Biology, vol. 24, no. 20, pp. 8917-8928, 2004.
16. X.-L. Xu, J. Yu, H.-Y. Zhang et al., "Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis, " World Journal of Gastroenterology, vol. 10, no. 23, pp. 3441-3454, 2004.
17. R. Yang, R. Morosetti, and H. P. Koeffler, "Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines, " Cancer Research, vol. 57, no. 5, pp. 913-920, 1997.
18. C. Muller, R. Yang, L. Beck-von-Peccoz, G. Idos, W. Verbeek, and H. P. Koeffler, "Cloning of the cyclin A1 genomic structure and characterization of the promoter region: GC boxes are essential for cell cycle-regulated transcription of the cyclin A1 gene, "The Journal of Biological Chemistry, vol. 274, no. 16, pp. 11220-11228, 1999.
19. N. Kitkumthorn, P. Yanatatsanajit, S. Kiatpongsan et al., "Cyclin A1 promoter hypermethylation in human papillomavirusassociated cervical cancer, " BMC Cancer, vol. 6, article 55, 2006.
20. P. Yanatatsaneejit, T. Chalermchai, V. Kerekhanjanarong et al., "Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma, " Oral Oncology, vol. 44, no. 4, pp. 400-406, 2008.
21. J. Yu, H. Y. Zhang, Z. Z. Ma, W. Lu, Y. F. Wang, and J. Zhu, "Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis, " Cell Research, vol. 13, no. 5, pp. 319-333, 2003.
22. J. Yu, T. Zhu, Z. Wang et al., "A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer, " Clinical Cancer Research, vol. 13, no. 24, pp. 7296-7304, 2007.
23. D. G. Altman, L. M. McShane, W. Sauerbrei, and S. E. Taube, "Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration, " PLoS Medicine, vol. 9, no. 5, Article ID e1001216, 2012.
24. A. Stang, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies inmetaanalyses, " European Journal of Epidemiology, vol. 25, no. 9, pp. 603-605, 2010.
25. D. Jackson, I. R. White, and R. D. Riley, "Quantifying the impact of between-study heterogeneity in multivariate meta-analyses, " Statistics in Medicine, vol. 31, no. 29, pp. 3805-3820, 2012.
26. J. L. Peters, A. J. Sutton, D. R. Jones, K. R. Abrams, and L. Rushton, "Comparison of two methods to detect publication bias in meta-analysis, " The Journal of the American Medical Association, vol. 295, no. 6, pp. 676-680, 2006.
27. E. Zintzaras and J. P. A. Ioannidis, "HEGESMA: genome search meta-analysis and heterogeneity testing, " Bioinformatics, vol. 21, no. 18, pp. 3672-3673, 2005.
28. Y. Y. Liu, J. L. Zhang, Y. H. Li et al., "Detection of CCNA1 gene methylation in Uyghur women with cervical cancer, " Maternal and Child Health Care of China, vol. 28, no. 11, pp. 1791-1792, 2013.
29. A. L. B. Longo, M. M. Rettori, A. C. De Carvalho, L. P. Kowalski, A. L. Carvalho, and A. L. Vettore, "Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma, " Head and Neck, vol. 36, no. 5, pp. 631-637, 2014.
30. S. Lim and P. Kaldis, "Cdks, cyclins and CKIs: roles beyond cell cycle regulation, " Development, vol. 140, no. 15, pp. 3079-3093, 2013.
31. M. S. Von Bergwelt-Baildon, E. Kondo, N. Klein-Gońzlez, and C. M. Wendtner, "The cyclins: a family of widely expressed tumor antigens?" Expert Review of Vaccines, vol. 10, no. 3, pp. 389-395, 2011.
32. C. H. Yam, T. K. Fung, and R. Y. C. Poon, "Cyclin A in cell cycle control and cancer, " Cellular andMolecular Life Sciences, vol. 59, no. 8, pp. 1317-1326, 2002.
33. R. Qi, H. An, Y. Yu et al., "Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis, " Cancer Research, vol. 63, no. 23, pp. 8323-8329, 2003.
34. H. Ma, J. Chen, S. Pan et al., "Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population, " Lung Cancer, vol. 73, no. 1, pp. 32-37, 2011.
35. J. Kim, W.-J. Kim, Z. Liu, M. F. Loda, and M. R. Freeman, "The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer, " Cell Cycle, vol. 11, no. 6, pp. 1123-1130, 2012.
36. M. M. Rettori, A. C. de Carvalho, A. L. B. Longo et al., "TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors, " Journal of Translational Medicine, vol. 11, no. 1, article 316, 2013.